May 20, 2019
Frelii Files Quarterly Report on Form 10-Q
LEHI, Utah–(BUSINESS WIRE)–Frelii Inc. (OTCQB: FRLI) (“Frelii” or “the Company”) today announced that on May 20, 2019, it filed with…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Frelii
May 1, 2019
Optivida Health, Frelii in deal for DNA sequencing services
Optivida will leverage Frelii’s proprietary DNAKit Packages™ to ensure Optivida customers can realize the optimalbenefits of which specific Optivida products best suit their unique DNAprofile.